US 6656930
Aralkyl diazabicycloalkane derivatives for CNS disorders
expired A61KA61K31/495A61P
Quick answer
US patent 6656930 (Aralkyl diazabicycloalkane derivatives for CNS disorders) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Nov 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Dec 02 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/495, A61P, A61P25/00